[Intrauterine reanimation].
D000138:Acidosis / Q000517:prevention & control; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D002395:Catecholamines / Q000627:therapeutic use; D004630:Emergencies; D005260:Female; D005315:Fetal Diseases / Q000517:prevention & control; D005316:Fetal Distress / Q000628:therapy*; D005323:Fetal Monitoring; D005333:Fetus; D005947:Glucose / Q000627:therapeutic use; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007743:Labor, Obstetric / Q000187:drug effects; D007773:Lactates / Q000096:biosynthesis; D008431:Maternal-Fetal Exchange / Q000187:drug effects; D010101:Oxygen Consumption; D011247:Pregnancy
D000319:Adrenergic beta-Antagonists; D002395:Catecholamines; D007773:Lactates; D005947:Glucose
Intrauterine Reanimation.